AKT1 and Insulin resistance: MSS may stimulate the PI3K/Akt/Foxo1 signaling pathway by mitigating chronic inflammation caused by a high-fat diet, therefore inhibiting excessive hepatic gluconeogenesis and ultimately improving insulin resistance.